Alkyl Amines Chemicals Limited’s board approved the unaudited financial results for the quarter and half-year ended September 30, 2025. Additionally, the board approved a revision in remuneration for Mr. Rakesh S. Goyal, Whole-time Director – Operations, effective January 1, 2026, subject to shareholder approval. The meeting concluded at 1:10 P.M.
Financial Performance – Q2 2026
The Board of Directors has approved the unaudited financial results for Q2 2026 (July-September) and the half-year ended September 30, 2025. Key financial highlights include:
- Revenue from Operations: ₹794.94 Crores for Half Year Ended September 30, 2025
- Total Revenue: ₹810.32 Crores for Half Year Ended September 30, 2025
- Profit before Tax: ₹125.45 Crores for Half Year Ended September 30, 2025
- Profit after Tax: ₹92.38 Crores for Half Year Ended September 30, 2025
- Earnings Per Share: ₹18.06 (Basic) and ₹18.04 (Diluted) (Not Annualized)
Remuneration Revision
Based on the recommendation of the Nomination and Remuneration Committee and subject to shareholder approval via postal ballot, the Board approved the revision in remuneration payable to Mr. Rakesh S. Goyal (Whole-time Director – Operations). This revision is effective from January 1, 2026, until the remainder of his tenure, expiring on May 31, 2027.
Source: BSE
